400-6699-1171000

分析测试百科网 认证会员,请放心拨打!

首页> 产品展示> Rivaroxaban

诚信认证:

工商注册信息已核实!

产品分类
微信二维码
QQ号咨询

点击这里给上海阿拉丁生化科技股份有限公司

药物分子

Rivaroxaban

品牌 厂商性质 产地 货期
阿拉丁 生产商 上海 现货

询价
产品参数
货号 CAS号 操作
R125138-50mg 366789-02-8 询价
R125138-250mg 366789-02-8 询价
R125138-1g 366789-02-8 询价
R125138-10mg 366789-02-8 询价
R125138-25g 366789-02-8 询价
R125138-5g 366789-02-8 询价
产品介绍

  • 分子式 C19H18ClN3O5S
  • 分子量435.88

属性

溶解性
  • DMSO 87 mg/mL
  • Ethanol <1 mg/mL
  • 存贮条件 储存温度-20°C

    描述

    产品介绍 Rivaroxaban is an oral, direct inhibitor of Factor X, being developed for the prevention and treatment of arterial and venous thrombosis with a Ki of 0.4 nM. Rivaroxaban also inhibits prothrombinase activity (IC50 = 2.1 nM). Rivaroxaban also shows a similar affinity to purified human (IC50 = 0.7 nM) and rabbit Factor X (IC50 = 0.8 nM), but a lesser potency against purified rat Factor X (IC50 = 3.4 nM). Endogenous human and rabbit Factor X in plasma is inhibited to a similar extent by Rivaroxaban (IC50 = 21 nM and 21 nM, respectively), while 14-fold higher concentrations are required in rat plasma (IC50 = 290 nM). Rivaroxaban exhibits high permeability and polarized transport across Caco-2 cells as a substrate of the P-gp, but exhibits no inhibitory effect on P-gp-mediated drug transport up to concentrations of 100 μM in vitro.
    备注 Rivaroxaban is a direct inhibitor of Factor Xa with Ki and IC50 of 0.4 nM and 0.7 nM, respectively.
    生化机理

    Rivaroxaban (Xarelto; BAY 59-7939) is a novel, oral, direct Factor Xa (FXa) inhibitor in late-stage development for the prevention and treatment of thromboembolic disorders. Rivaroxaban (Xarelto; BAY 59-7939) inhibits clot-associated,free FXa activity,and prothrombinase activity, in addition, it reduces thrombin generation. Rivaroxaban (Xarelto; BAY 59-7939) is useful for antithrombotic agent

    别名 利伐沙班;(S)-5-chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)thiophene-2-carboxamide

    Rivaroxaban信息由上海阿拉丁生化科技股份有限公司为您提供,如您想了解更多关于Rivaroxaban报价、型号、参数等信息,欢迎来电或留言咨询。

    注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途